18% Function PKD, What Should Do

PKD,18% Function,Micro-Chinese Medicine OsmotherapyPKD as a kind of inherited kidney disease, in most condition that patients will have high blood pressure, high serum creatinine in and kidney failure in the end. It usually develops slowly.

According to GFR, CKD is classified into five stages. Now you have 18% function, it indicates that you are in stage 4, when you are often required to prepare for dialysis or kidney transplant. Do you want any of them? If not, you should improve your renal function timely.

How to improve 18% function for PKD patients?

At present, our hospital provides conservative treatment named Micro-Chinese Medicine Osmotherapy. It is an external administration rather than oral medicine. You can take this treatment just by lying on their back. The mechanism of this treatment is to dilate blood vessels, restrain the hyperplasia of endothelial cells and the secretion of cystic liquids as well as increase the permeability of cyst wall. After a period of treatment, cysts can be halted from from further enlargement and even shrink gradually. In this case, these cysts will not press kidney tissues anymore so that your residual renal function can be protected. Compared with other treatment, it is more safe and convenient and it will not cause nay side effects. Under normal circumstance, after about half month’s treatment, you can see your kidneys become small, and associated symptoms such as high blood pressure and back pain will get relieved. After about months’ treatment, your kidney function will regain.

If you want to know more about Micro-Chinese Medicine Osmotherapy or other conservative treatment for PKD without surgery, you can contact with us as soon as possible. We will reply you in 24 hours.

Email: kidneyabc@hotmail.com

Skype:abc.kidney

viber/whatsapp: +86 18831112890, +86 13503211882

Previous:What are Effective Chinese Medicine Treatment for PKD Patients

Next:Is There Any Medicine For PKD to Reduce Creatinine 9.6

Tag:PKD TreatmentPKD18% Function

  • Gender: